Within the Women Healthcare Market , postmenopausal osteoporosis holds the largest share, reflecting the significant burden of this condition on aging women. According to the MRFR report, postmenopausal osteoporosis is a critical concern for women's health post-menopause, characterized by decreased bone density and increased fracture risk. The segment's dominance is driven by the large and growing population of postmenopausal women and the availability of effective diagnostic tools (bone densitometry) and therapeutic options (bisphosphonates, hormone therapy). The postmenopausal osteoporosis segment was valued at a significant portion of the market.

While postmenopausal osteoporosis leads, infertility is the fastest-growing segment. This growth is driven by changing societal norms, delayed childbearing, and advances in reproductive technologies. Infertility is a growing concern globally, affecting millions of couples. The increasing awareness of infertility treatments and the expanding availability of assisted reproductive technologies (ART), such as in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI), are driving demand. The infertility segment is projected to grow rapidly, capturing an increasing share of the market.

Reproductive health management is another significant segment, encompassing a range of services including contraception, menstrual health, and prenatal care. The growing focus on family planning and women's reproductive rights is driving demand for these services. Polycystic ovary syndrome (PCOS) and gynecologic cancers (such as cervical, ovarian, and uterine cancer) represent other important segments. PCOS is a common hormonal disorder affecting women of reproductive age, while gynecologic cancers are a leading cause of cancer death among women. The focus on early detection and innovative treatments is driving growth in these segments.

The segmentation by indication highlights the diversity of women's healthcare needs. Postmenopausal osteoporosis remains a major concern, but the rapid growth of infertility services reflects the changing demographics and societal trends. The increasing focus on reproductive health management and the growing burden of PCOS and gynecologic cancers are also driving market expansion.

The diagnosis and treatment segment is dominated by bone densitometry for osteoporosis screening, while ovulation testing is the fastest-growing segment, driven by rising fertility awareness and the increasing inclination towards home-based testing solutions.